Engineered skin substitutes: practices and potentials.

[1]  S. Boyce,et al.  Autologous cultured skin substitutes conserve donor autograft in elective treatment of congenital giant melanocytic nevus. , 2004, Plastic and reconstructive surgery.

[2]  J. Still,et al.  The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. , 2003, Burns : journal of the International Society for Burn Injuries.

[3]  S. MacNeil,et al.  Development of a stable chemically defined surface for the culture of human keratinocytes under serum-free conditions for clinical use. , 2003, Tissue engineering.

[4]  D. Fivenson,et al.  Apligraf in the treatment of severe mitten deformity associated with recessive dystrophic epidermolysis bullosa. , 2003, Plastic and reconstructive surgery.

[5]  S. Wolfe,et al.  Use of Skin Substitutes in Pediatric Patients , 2003, The Journal of craniofacial surgery.

[6]  Nicola J Brown,et al.  Development of a reconstructed human skin model for angiogenesis , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[7]  D. Wisser,et al.  Skin replacement with a collagen based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma. , 2003, Burns : journal of the International Society for Burn Injuries.

[8]  H. Merk,et al.  Radical Resection of Giant Congenital Melanocytic Nevus and Reconstruction With Meek‐Graft Covered Integra Dermal Template , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  E. Rodriguez,et al.  Revascularization of Human Acellular Dermis in Full-Thickness Abdominal Wall Reconstruction in the Rabbit Model , 2003, Annals of plastic surgery.

[10]  Robert R Lorenz,et al.  Endoscopic Reconstruction of Anterior and Middle Cranial Fossa Defects Using Acellular Dermal Allograft , 2003, The Laryngoscope.

[11]  J. Hanft,et al.  Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. , 2002, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[12]  June Chen,et al.  Graftskin Treatment of Difficult to Heal Diabetic Foot Ulcers: One Center's Experience , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[13]  V. Falanga,et al.  The longevity of a bilayered skin substitute after application to venous ulcers. , 2002, Archives of dermatology.

[14]  D. Supp,et al.  Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Rockne Stephens,et al.  A premature infant with skin injury successfully treated with bilayered cellular matrix. , 2002, Ostomy/wound management.

[16]  S. Boyce,et al.  Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes. , 2002, The Journal of investigative dermatology.

[17]  D. Greenhalgh,et al.  Cultured Skin Substitutes Reduce Donor Skin Harvesting for Closure of Excised, Full-Thickness Burns , 2002, Annals of surgery.

[18]  A. Thody,et al.  Melanocyte Function and Its Control by Melanocortin Peptides , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  J. Uitto,et al.  Molecular genetics of heritable blistering disorders. , 2001, Archives of dermatology.

[20]  M. Seiberg.  Keratinocyte-melanocyte interactions during melanosome transfer. , 2001, Pigment cell research.

[21]  M. del Río,et al.  A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin‐targeted keratinocyte grafts , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  P. Khavari,et al.  In vivo restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Falabella,et al.  Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. , 2000, Archives of dermatology.

[24]  A. Marghoob,et al.  Large Congenital Melanocytic Nevi and the Risk for Development of Malignant Melanoma and Neurocutaneous Melanocytosis , 2000, Pediatrics.

[25]  S. Lal,et al.  Biobrane improves wound healing in burned children without increased risk of infection. , 2000, Shock.

[26]  G Tellides,et al.  In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Carsin,et al.  Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. , 2000, Burns : journal of the International Society for Burn Injuries.

[28]  S. Boyce,et al.  The 1999 clinical research award. Cultured skin substitutes combined with Integra Artificial Skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. , 1999, The Journal of burn care & rehabilitation.

[29]  A. Falabella,et al.  The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. , 1999, Archives of dermatology.

[30]  J. M. Arévalo,et al.  Skin coverage with Biobrane biomaterial for the treatment of patients with toxic epidermal necrolysis. , 1999, The Journal of burn care & rehabilitation.

[31]  S. Boyce,et al.  Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[32]  J. Hansbrough,et al.  Safety and efficacy of TransCyte for the treatment of partial-thickness burns. , 1999, The Journal of burn care & rehabilitation.

[33]  F. Lönnqvist,et al.  Leptin and its potential role in human obesity , 1999, Journal of internal medicine.

[34]  J. Guilhou,et al.  [Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent]. , 1999, Annales de dermatologie et de venereologie.

[35]  L. Naumovski,et al.  Endothelial cell apoptosis in capillary network remodeling , 1999, Journal of cellular physiology.

[36]  D. Mooney,et al.  Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. , 1999, The American journal of pathology.

[37]  R. Sheridan,et al.  Acellular allodermis in burns surgery: 1-year results of a pilot trial. , 1998, The Journal of burn care & rehabilitation.

[38]  Lucie Germain,et al.  In vitro reconstruction of a human capillary‐like network in a tissue‐engineered skin equivalent , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  J. Ortonne,et al.  Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia , 1998, Gene Therapy.

[40]  G. Pellegrini,et al.  Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. , 1998, Human gene therapy.

[41]  P. Margaritis,et al.  Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo. , 1998, Human gene therapy.

[42]  S. Boyce,et al.  Regulation of pigmentation in cultured skin substitutes by cytometric sorting of melanocytes and keratinocytes. , 1997, The Journal of investigative dermatology.

[43]  G. Brownlee,et al.  An ex vivo keratinocyte model for gene therapy of hemophilia B. , 1997, The Journal of investigative dermatology.

[44]  C. Brandt,et al.  Improved survival of adults with extensive burns. , 1997, Journal of Burn Care and Rehabilitation.

[45]  M. Raghunath,et al.  Efficacy of cultured epithelial autografts in pediatric burns and reconstructive surgery. , 1997, Surgery.

[46]  S. Boyce,et al.  Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice , 1997, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[47]  J. K. Rose,et al.  Advances in the treatment of burn patients. , 1997, Burns : journal of the International Society for Burn Injuries.

[48]  H. Kurzen,et al.  The distribution of the desmosomal protein, plakophilin 1, in human skin and skin tumors. , 1997, The Journal of investigative dermatology.

[49]  D. Mauri,et al.  Successful treatment of chronic leg ulcers with epidermal equivalents generated from cultured autologous outer root sheath cells. , 1996, The Journal of investigative dermatology.

[50]  S. Boyce,et al.  Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice. , 1996, The Journal of investigative dermatology.

[51]  J. Hunt,et al.  Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. , 1996, The Journal of burn care & rehabilitation.

[52]  D. Greenhalgh,et al.  Comparative Assessment of Cultured Skin Substitutes and Native Skin Autograft for Treatment of Full‐Thickness Burns , 1995, Annals of surgery.

[53]  W. Eaglstein,et al.  A Composite Skin Substitute (Graftskin) for Surgical Wounds: A Clinical Experience , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[54]  A. Weerheim,et al.  Triglyceride metabolism in human keratinocytes cultured at the air-liquid interface , 1995, Archives of Dermatological Research.

[55]  D. Greenhalgh,et al.  Pigmentation and microanatomy of skin regenerated from composite grafts of cultured cells and biopolymers applied to full-thickness burn wounds. , 1995, Transplantation.

[56]  D. Greenhalgh,et al.  Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. , 1995, The Journal of investigative dermatology.

[57]  E. Fenjves.  Approaches to gene transfer in keratinocytes. , 1994, The Journal of investigative dermatology.

[58]  L. Taichman,et al.  Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. , 1994, Human gene therapy.

[59]  P. Vogt,et al.  Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Echinard.  Artificial skin in massive burns — results to ten years , 1994, European Journal of Plastic Surgery.

[61]  L. Bolund,et al.  Gene transfer into cultured human epidermis and its transplantation onto immunodeficient mice: an experimental model for somatic gene therapy. , 1994, The Journal of investigative dermatology.

[62]  B. Stanton,et al.  A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. , 1994, Journal of the American Academy of Dermatology.

[63]  T. Phillips,et al.  Chronic cutaneous ulcers: etiology and epidemiology. , 1994, The Journal of investigative dermatology.

[64]  T. Sun,et al.  Upper human hair follicle contains a subpopulation of keratinocytes with superior in vitro proliferative potential. , 1993, The Journal of investigative dermatology.

[65]  S. Boyce,et al.  Selection of Topical Antimicrobial Agents for Cultured Skin for Burns by Combined Assessment of Cellular Cytotoxicity and Antimicrobial Activity , 1993, Plastic and reconstructive surgery.

[66]  S. Boyce,et al.  Lipid supplemented medium induces lamellar bodies and precursors of barrier lipids in cultured analogues of human skin. , 1993, The Journal of investigative dermatology.

[67]  V. Falanga.  Chronic wounds: pathophysiologic and experimental considerations. , 1993, The Journal of investigative dermatology.

[68]  D. Greenhalgh,et al.  Skin anatomy and antigen expression after burn wound closure with composite grafts of cultured skin cells and biopolymers. , 1993, Plastic and reconstructive surgery.

[69]  F. Watt,et al.  Towards gene therapy for haemophilia B using primary human keratinocytes , 1993, Nature Genetics.

[70]  O. Damour,et al.  Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. , 1992, Burns : journal of the International Society for Burn Injuries.

[71]  J. Hansbrough,et al.  Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. , 1992, The Journal of burn care & rehabilitation.

[72]  Carolyn Compton,et al.  Current Concepts in Pediatric Burn Care: The Biology of Cultured Epithelial Autografts: An Eight-Year Study in Pediatric Burn Patients* , 1992, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[73]  M L Cooper,et al.  In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. , 1991, Biomaterials.

[74]  D. Gordon,et al.  Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[75]  S. Boyce,et al.  Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. , 1989, JAMA.

[76]  M. Mannik.  Development of immune complexes in the skin. , 1989, The Journal of investigative dermatology.

[77]  R. Barrow,et al.  A Comparison of Conservative Versus Early Excision: Therapies in Severely Burned Patients , 1989, Annals of surgery.

[78]  Z. Abdel‐Malek,et al.  Pigment cell biology: an historical review. , 1989, The Journal of investigative dermatology.

[79]  D. Heimbach,et al.  Artificial Dermis for Major Burns: A Multi‐Center Randomized Clinical Trial , 1988, Annals of surgery.

[80]  S. Boyce,et al.  Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. , 1988, Surgery.

[81]  Z. Abdel‐Malek,et al.  Endocrine factors as effectors of integumental pigmentation. , 1988, Dermatologic clinics.

[82]  Y. Barrandon,et al.  Expression of an exogenous growth hormone gene by transplantable human epidermal cells. , 1987, Science.

[83]  J. Hunt,et al.  Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. , 1987, The Journal of trauma.

[84]  S. Boyce,et al.  Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media , 1985 .

[85]  S. Boyce,et al.  Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. , 1983, The Journal of investigative dermatology.

[86]  D. Woodley,et al.  Methods for cultivation of keratinocytes with an air-liquid interface. , 1983, The Journal of investigative dermatology.

[87]  R. Bartlett,et al.  A new composite skin prosthesis , 1980 .

[88]  I. Yannas,et al.  Design of an artificial skin. II. Control of chemical composition. , 1980, Journal of biomedical materials research.

[89]  H. Green,et al.  Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma , 1975, Cell.

[90]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[91]  William L Hickerson,et al.  Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. , 2003, The Journal of burn care & rehabilitation.

[92]  D. Supp,et al.  Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes. , 2002, The Journal of burn care & rehabilitation.

[93]  G. Plosker,et al.  Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. , 2002, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[94]  D. Supp,et al.  Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor. , 2000, The Journal of investigative dermatology.

[95]  L D Solem,et al.  A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. , 1997, The Journal of burn care & rehabilitation.

[96]  J. Hansbrough,et al.  Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. , 1997, The Journal of burn care & rehabilitation.

[97]  T. Bunting,et al.  The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. , 1993, The Journal of trauma.

[98]  B. Gilchrest,et al.  Cultured epidermal grafts in the treatment of leg ulcers. , 1990, Advances in dermatology.

[99]  I. Yannas,et al.  Design of an artificial skin. I. Basic design principles. , 1980, Journal of biomedical materials research.

[100]  H Green,et al.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. , 1975, Cell.